HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mahmoud E S Soliman Selected Research

Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)

1/2020In Silico Repurposing of J147 for Neonatal Encephalopathy Treatment: Exploring Molecular Mechanisms of Mutant Mitochondrial ATP Synthase.
9/2019Broadening the horizon: Integrative pharmacophore-based and cheminformatics screening of novel chemical modulators of mitochondria ATP synthase towards interventive Alzheimer's disease therapy.
6/2019Deciphering the 'Elixir of Life': Dynamic Perspectives into the Allosteric Modulation of Mitochondrial ATP Synthase by J147, a Novel Drug in the Treatment of Alzheimer's Disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mahmoud E S Soliman Research Topics

Disease

24Neoplasms (Cancer)
09/2022 - 01/2015
8Alzheimer Disease (Alzheimer's Disease)
02/2021 - 01/2018
6Neurodegenerative Diseases (Neurodegenerative Disease)
03/2022 - 01/2017
6COVID-19
01/2022 - 01/2020
6Tuberculosis (Tuberculoses)
04/2020 - 12/2016
5Carcinogenesis
01/2022 - 03/2018
4Malaria
02/2022 - 06/2018
3Infections
11/2020 - 01/2018
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
07/2022 - 01/2022
2Lung Neoplasms (Lung Cancer)
05/2022 - 08/2021
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2022 - 03/2019
2Prostatic Neoplasms (Prostate Cancer)
12/2021 - 01/2020
2Nervous System Diseases (Neurological Disorders)
11/2021 - 01/2021
2Glioma (Gliomas)
10/2021 - 05/2021
2Parkinson Disease (Parkinson's Disease)
03/2021 - 01/2021
2Inflammation (Inflammations)
03/2020 - 01/2015
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2019 - 03/2018
2Dengue (Dengue Fever)
01/2018 - 11/2014
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2022
1Lymphoma (Lymphomas)
07/2022
1Sarcoma (Soft Tissue Sarcoma)
05/2022
1Colorectal Neoplasms (Colorectal Cancer)
03/2022
1Lung Injury
01/2022
1Hyperglycemia
01/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1Diabetes Complications
01/2022
1Colonic Neoplasms (Colon Cancer)
07/2021
1autosomal dominant Spastic paraplegia 6
03/2021
1Cryptosporidiosis
01/2021
1Substance-Related Disorders (Drug Abuse)
01/2021
1Schizophrenia (Dementia Praecox)
01/2021
1Rubinstein-Taybi Syndrome (Syndrome, Rubinstein-Taybi)
01/2021
1Extensively Drug-Resistant Tuberculosis
04/2020
1Acute Lung Injury
03/2020

Drug/Important Bio-Agent (IBA)

16Pharmaceutical PreparationsIBA
05/2022 - 12/2016
10EnzymesIBA
09/2022 - 01/2015
10Proteins (Proteins, Gene)FDA Link
05/2022 - 11/2014
4Monoamine Oxidase (MAO)IBA
03/2022 - 01/2017
4Peptide Hydrolases (Proteases)FDA Link
01/2021 - 11/2016
3Poly (ADP-Ribose) Polymerase-1IBA
09/2022 - 01/2021
3TankyrasesIBA
09/2022 - 01/2019
3LigandsIBA
01/2022 - 01/2018
3VaccinesIBA
06/2021 - 10/2015
3J147IBA
01/2020 - 06/2019
3Mitochondrial Proton-Translocating ATPases (Mitochondrial ATP Synthase)IBA
01/2020 - 06/2019
3plasmepsin (plasmepsin I)IBA
12/2019 - 06/2018
2Antiviral Agents (Antivirals)IBA
06/2021 - 10/2015
2RNA-Dependent RNA Polymerase (RNA Dependent RNA Polymerase)IBA
01/2021 - 01/2018
2bedaquiline (R207910)IBA
04/2020 - 01/2019
2Phosphoprotein Phosphatases (Phosphatases, Protein)IBA
12/2019 - 11/2018
2Adenosine Triphosphate (ATP)IBA
09/2019 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
01/2019 - 12/2016
1ImidazolidinesIBA
09/2022
1talazoparibIBA
09/2022
1venetoclaxIBA
07/2022
1Agammaglobulinaemia Tyrosine KinaseIBA
06/2022
1Oncogene Proteins (Oncogene Protein)IBA
05/2022
1adagrasibIBA
05/2022
1Codon (Codons)IBA
05/2022
1sotorasibIBA
05/2022
1Anaplastic Lymphoma KinaseIBA
05/2022
1QuinazolinonesIBA
03/2022
1CateninsIBA
03/2022
1Antimalarials (Antimalarial Agents)IBA
02/2022
1Matrix Metalloproteinases (MMPs)IBA
01/2022
1InterleukinsIBA
01/2022
1AntioxidantsIBA
01/2022
1Deubiquitinating EnzymesIBA
01/2022
1Aldehyde Reductase (Aldose Reductase)IBA
01/2022
1Membrane Proteins (Integral Membrane Proteins)IBA
01/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2022
1benzamideIBA
12/2021
1Temozolomide (Temodar)FDA LinkGeneric
10/2021
1ChlorineIBA
08/2021
1Retinoid X Receptors (Retinoid X Receptor)IBA
07/2021
1BerberineIBA
07/2021
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
05/2021
1vorasidenibIBA
05/2021
1CarbonIBA
03/2021
1Purinergic P1 Receptors (Adenosine Receptor)IBA
03/2021
1benzofuranIBA
03/2021
1SirtuinsIBA
02/2021
1Paromomycin (Paromomycin Sulfate)FDA LinkGeneric
01/2021
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2021
1remdesivirIBA
01/2021
1Subunit VaccinesIBA
01/2021
1Dopamine Receptors (Dopamine Receptor)IBA
01/2021
1Heme Oxygenase-1IBA
01/2021
1HSP72 Heat-Shock ProteinsIBA
01/2021
1Caspase 6IBA
09/2020
12,4-diaminopyrimidineIBA
03/2020
1benzothiopheneIBA
03/2020
1CRTH2 antagonist CT-133IBA
03/2020
1LipidsIBA
03/2020

Therapy/Procedure

22Therapeutics
09/2022 - 11/2018
3Drug Therapy (Chemotherapy)
10/2021 - 01/2017
2Immunotherapy
01/2020 - 01/2020
1Castration
12/2021
1Aftercare (After-Treatment)
11/2020
1Ligation
03/2020